Cybrexa Therapeutics
Manufacturing · Connecticut, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
395 Winchester Ave, New Haven, Connectic...Phone Number
(860) 717-2731Website
www.cybrexa.comRevenue
$5.3 MillionIndustry
About Cybrexa Therapeutics
Cybrexa Therapeutics is a clinical-stage biotechnology company focused on developing novel antigen-independent, tumor-targeting peptide-drug conjugate (PDC) therapeutics. The company aims to revolutionize cancer treatment through its proprietary alphalex technology platform, which enhances the intracellular delivery of potent anti-cancer agents. Targeting a range of solid tumors, including breast, ovarian, and non-small cell lung cancer, Cybrexa is dedicated to improving patient outcomes and expanding treatment options. Founded in 2017 and based in New Haven, Connecticut, Cybrexa is led by a team of experienced life science entrepreneurs and drug development scientists.Explore more
Cybrexa Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Cybrexa Therapeutics
Compare insights from companies similar to Cybrexa Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Cybrexa Therapeutics Tech Stack
A closer look at the technologies used by Cybrexa Therapeutics
Top Manufacturing Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Cybrexa Therapeutics
Sign Up For FreeTo access detailed company insights
Cybrexa Therapeutics is a clinical-stage biotechnology company focused on developing novel antigen-independent, tumor-targeting peptide-drug conjugate (PDC) therapeutics. The company aims to revolutionize cancer treatment through its proprietary alphalex technology platform, which enhances the intracellular delivery of potent anti-cancer agents. Ta... Read More
